SUSCEPTIBILITY TO ANTIBIOMICROBIAL AGENTS - PHENOTYPICAL DIFFERENTIATION BETWEEN BORDETELLA-BRONCHISEPTICA, ALCALIGENES-FAECALIS, AND A-XYLOSOXYDANS

被引：3

作者：

PHILIPPON, A

ARLET, G

CHEBBI, F

GUISO, N

机构：

[1] Hôpital Saint-Louis, Service de Bactériologie-Virologie, F-75010 Paris

[2] Institut Pasteur, Unité d'Ecologie Bactérienne, F-75724 Paris cedex 15

来源：

MEDECINE ET MALADIES INFECTIEUSES | 1991年 / 21卷 / 10期

关键词：

B-BRONCHISEPTICA; A-FAECALIS; A-DENITRIFICANS SUBSP XYLOSOXYDANS; SUSCEPTIBILITY TO ANTIMICROBIAL AGENTS;

D O I：

10.1016/S0399-077X(05)80901-1

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The susceptibility of 23 strains of B. bronchiseptica has been examinated by agar diffusion method. All the strains were susceptible to amoxicillin, ticarcillin, mezlocillin, piperacillin, cefoperazone, moxalactam, imipenem, kanamycin, gentamicin, netilmicin, amikacin, nalidixic acid, pefloxacin, ciprofloxacin, sulphonamides, erythromycin and intermediate or resistant to mecillinam, cephalothin, cefamandole, cefoxitin, cefotaxime, cefuroxime, aztreonam, streptomycin, spectinomycin, pipemidic acid, fosfomycin, and trimethoprim. The susceptibility patterns of beta-lactams individualized a beta-lactamase phenotype (a synergy was demonstrated between amoxicillin and clavulanic acid). The comparative study of the susceptibility to some beta-lactams (e.g. cefamandole and cefotaxime) and aminoglycosides (e.g. gentamicin) showed a easy differentiation between strains of B. bronchiseptica, A. faecalis and A. xylosoxydans.

引用

页码：627 / 632

页数：6

共 13 条

[1]

Acar, Bergogne-Berezin, Cluzel, Courtieu, Courvalin, Dabernat, Drugeon, Duval, Fleurette, Morel, Philippon, Sirot, Soussy, Thabaut, Veron, Communiqué 1989 du Comité de l'Antibiogramme de la Société Française de Microbiologie, Path Biol., 7, pp. 857-860, (1989)

[2]

Bizet, Mensah, Philippon, Sensibilité de Alcaligenes faecalis vis-à-vis de 31 antibiotiques — comparaison avec celle de Alcaligenes denitrificans subsp. xylosoxydans, Méd Mal Infect, 20, pp. 148-152, (1990)

[3]

Courvalin, Goldstein, Philippon, Sirot, Détermination de la concentration minimale inhibitrice en milieu solide, L'Antibiogramme, pp. 195-198, (1985)

[4]

Goodnow, Biology of Bordetella bronchiseptica, Microbiol Rev, 44, pp. 722-738, (1980)

[5]

Ishikawa, Isayama, Ohmae, Decrease in antimicrobial susceptibility of Bordetella bronchiseptica caused by antigenic modulation and phase variation, Antimicrob Agents Chemother, 32, pp. 1891-1892, (1988)

[6]

Johnson, Sneath, Taxonomy of Bordetella and related organisms of the families Achromobactericeae, Brucellaceae, and Neisseriaceae, Int J Syst Bact., 23, pp. 381-404, (1973)

[7]

Kiredjian, Popoff, Coynault, Lefevre, Lemelin, Taxonomie du genre Alcaligenes, Ann Microbiol (Inst Pasteur), 132 B, pp. 337-374, (1981)

[8]

Kurzynski, Boehm, Rott-Petri, Schell, Allison, Antimicrobial susceptibilities of Bordetella species isolated in a multicenter pertussis surveillance project, Antimicrob Agents Chemother, 32, pp. 137-140, (1988)

[9]

Meis, van Griethuijena, Muytjens, Bordetella bronchiseptica bronchitis in an immunosuppressed patient, Europ J Clin Microbiol Infect Dis, 9, pp. 366-367, (1990)

[10]

Mortensen, Brumbach, Shryock, Antimicrobial susceptibility of Bordetella avium and Bordetella bronchiseptica caused by antigenic modulation and phase variation, Antimicrobial Agents and Chemotherapy, 33, pp. 771-772, (1988)

← 1 2 →